These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26272591)

  • 1. Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.
    Bentin Toaldo C; Alexi X; Beelen K; Kok M; Hauptmann M; Jansen M; Berns E; Neefjes J; Linn S; Michalides R; Zwart W
    BMC Cancer; 2015 Aug; 15():588. PubMed ID: 26272591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer.
    Kok M; Zwart W; Holm C; Fles R; Hauptmann M; Van't Veer LJ; Wessels LF; Neefjes J; Stål O; Linn SC; Landberg G; Michalides R
    Breast Cancer Res Treat; 2011 Jan; 125(1):1-12. PubMed ID: 20213082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1.
    Zwart W; Griekspoor A; Berno V; Lakeman K; Jalink K; Mancini M; Neefjes J; Michalides R
    EMBO J; 2007 Aug; 26(15):3534-44. PubMed ID: 17627277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.
    Michalides R; Griekspoor A; Balkenende A; Verwoerd D; Janssen L; Jalink K; Floore A; Velds A; van't Veer L; Neefjes J
    Cancer Cell; 2004 Jun; 5(6):597-605. PubMed ID: 15193262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance.
    de Leeuw R; Flach K; Bentin Toaldo C; Alexi X; Canisius S; Neefjes J; Michalides R; Zwart W
    Oncogene; 2013 Jul; 32(30):3543-51. PubMed ID: 22907427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
    Bostner J; Alayev A; Berman AY; Fornander T; Nordenskjöld B; Holz MK; Stål O
    Breast Cancer Res Treat; 2018 Feb; 168(1):17-27. PubMed ID: 29128895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
    J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.
    Plaza-Menacho I; Morandi A; Robertson D; Pancholi S; Drury S; Dowsett M; Martin LA; Isacke CM
    Oncogene; 2010 Aug; 29(33):4648-57. PubMed ID: 20531297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKAP13 Enhances CREB1 Activation by FSH in Granulosa Cells.
    Cayton Vaught KC; Hazimeh D; Carter AS; Devine K; Maher JY; Maguire M; McGee EA; Driggers PH; Segars JH
    Reprod Sci; 2023 May; 30(5):1528-1539. PubMed ID: 36401072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells.
    Zhuang T; Zhu J; Li Z; Lorent J; Zhao C; Dahlman-Wright K; Strömblad S
    Oncotarget; 2015 Dec; 6(41):43853-68. PubMed ID: 26554417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKAP13 couples GPCR signaling to mTORC1 inhibition.
    Zhang S; Wang H; Melick CH; Jeong MH; Curukovic A; Tiwary S; Lama-Sherpa TD; Meng D; Servage KA; James NG; Jewell JL
    PLoS Genet; 2021 Oct; 17(10):e1009832. PubMed ID: 34673774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway.
    Gao A; Sun T; Ma G; Cao J; Hu Q; Chen L; Wang Y; Wang Q; Sun J; Wu R; Wu Q; Zhou J; Liu L; Hu J; Dong JT; Zhu Z
    Nat Commun; 2018 Oct; 9(1):4180. PubMed ID: 30301939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer.
    Wei C; Cao Y; Yang X; Zheng Z; Guan K; Wang Q; Tai Y; Zhang Y; Ma S; Cao Y; Ge X; Xu C; Li J; Yan H; Ling Y; Song T; Zhu L; Zhang B; Xu Q; Hu C; Bian XW; He X; Zhong H
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):E601-10. PubMed ID: 24449872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.
    Shrivastav A; Bruce M; Jaksic D; Bader T; Seekallu S; Penner C; Nugent Z; Watson P; Murphy L
    Breast Cancer Res; 2014 May; 16(3):R49. PubMed ID: 24887419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.
    Zhang B; Zhang X; Tang B; Zheng P; Zhang Y
    Breast Cancer Res Treat; 2012 Nov; 136(2):399-406. PubMed ID: 23053650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
    Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
    Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.